Back to search
Nonfluent Aphasia, Progressive
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Nonfluent Aphasia, Progressive trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Nonfluent Aphasia, Progressive trials you may qualify forWhile many have strongly suggested that transcranial direct current stimulation (tDCS) may represent a beneficial intervention for patients with primary progres…
The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and testing.
The goal of this exploratory study is to evaluate the effect of neflamapimod in participants with nonfluent variant primary progressive aphasia (nfvPPA). We aim…
The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and qua…
The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is u…
The purpose of this study is to further define the neurological and linguistic deterioration in primary progressive aphasia.
The purpose of this study is to determine safety, tolerability, and pharmacokinetics/dynamics of a ketogenic dietary supplement containing medium chain triglyce…
Primary progressive aphasia (PPA) is a progressive neurological disorder that causes a gradual decline in communication ability as a result of selective neurode…